Susceptibility of Shigella species to erythromycin | Zendy

Richard N. Greenberg | Zendy; Richard D. Pearson | Zendy; D J Innes | Zendy; K T Sauer | Zendy; L D Halterman | Zendy; Richard L. Guerrant | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Susceptibility of Shigella species to erythromycin

Author(s) -

Richard N. Greenberg,

Richard D. Pearson,

D J Innes,

K T Sauer,

L D Halterman,

Richard L. Guerrant

Publication year - 1982

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.21.2.347

Subject(s) - shigellosis , erythromycin , shigella , microbiology and biotechnology , campylobacter jejuni , biology , enteritis , antimicrobial , antibiotics , campylobacter fetus , shigella flexneri , macrolide antibiotics , bacteria , escherichia coli , salmonella , biochemistry , genetics , gene

Two of the most common causes of inflammatory enteritis are Campylobacter fetus subsp. jejuni and Shigella species. No single antimicrobial agent is recommended for treatment of both diseases. Erythromycin is used to treat C. fetus subsp. jejuni infections but has not been studied in shigellosis. For this reason, we determined the susceptibility of 22 strains of Shigella to erythromycin and found that Shigella species are susceptible to concentrations of erythromycin which are obtainable in stool.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research